Fall Schedule
| SEPTEMBER | ||
|
September 9 |
Paul Fitzpatrick, Ph.D. Department of Biochemistry Regulation of Tyrosine Hydroxylase by Phosphorylation and Feedback Inhibition |
|
|
September 16 |
Marilyn McGinnis, Ph.D. Department of Pharmacology Adolescent anabolic steroid use: Is it harmless? |
|
|
September 23 |
Elisabeth Van Bockstaele, Ph.D. Professor Neurosurgery Cannabinoid modulation of noradrenergic circuits: Implications of behavior |
|
|
September 30 |
Mark Von Zastrow, Ph.D. (BRIGGS Lecture) Associate Professor of Psychiatry and Cellular/Molecular Pharmacology Regulation of signaling receptors by endocytic membrane traffic |
|
| OCTOBER | ||
|
October 7 |
Sunil Sudarshan, M.D. Department of Urology TBA |
|
|
October 14 |
NO SEMINAR (week before SfN) |
|
|
October 21 |
NO SEMINAR (SfN October 17-21) |
|
|
October 28 |
F. Ivy Carroll, Ph.D. Center for Organic and Medicinal Chemistry Development of selective kappa opioid receptor antagonists |
|
| NOVEMBER | ||
|
November 4 |
David R. Sibley, Ph.D. Chief, Molecular Neuropharmacology Section Novel mechanisms of dopamine receptor regulation |
|
|
November 11 |
S. John Mihic, Ph.D. Institute for Neuroscience Section of Neurobiology and Waggoner Disruption of an inter-subunit electrostatic bond constitutes an initial step in glycine receptor activation: Implications for agonism and partial agonism |
|
|
November 18 |
Milton L. Brown, M.D., Ph.D. Von Matsch Endowed Chair in Experimental Therapeutics; Diector, Drug Discovery Program Developing new prostate cancer therapueutics |
|
|
November 25 |
NO SEMINAR (Thanksgiving Week) |
|
| DECEMBER | ||
|
December 2 |
Robert Dantzer, Ph.D. Intregrative Immunology and Behavior Program Why do we feel sick and behave in a sick way when we are ill? A case of immune-to-brain communication |
|
|
December 9 |
NO SEMINAR (ACNP December 6-10) |
|
|
December 16 |
Addanki Pratap Kumar, Ph.D. Department of Urology Natural products for cancer management: Myth or reality? |
|